Company

Carcinotech

Biotechnology Research Campus, United Kingdom 16 employees

Employees: 16
Contacts: 3
Emails: 3

carcinotech.co.uk LinkedIn

Carcinotech Overview

Headquarters: Campus, United Kingdom
Website: carcinotech.co.uk
Industry: Biotechnology Research
Employees: 16
Founded: 2018
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cancer research 3D bioprinting Cancer microenvironment drug testing oncology assay services oncology pre-clinical services solid tumours solid tumors tumour microenvironment tumor microenvironment early phase drug development

About Carcinotech

Carcinotech provides comprehensive solid tumor research services to advance drug development and enhance personalized therapy decisions. At the heart of its offerings is the proprietary Carcino3D™ bioprinting technology, which creates assay-ready, 3D tumors derived from patient biopsies. This innovative, translational approach delivers a predictive in vitro model, generating critical insights into therapeutic efficacy, and treatment optimization.

Carcinotech Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Carcinotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
David Milroy		Edinburgh, Scotland, United Kingdom	Email
Lorna Ewart	C-suite Executive - Pharma & Life Sciences	Greater Cambridge Area, United Kingdom	Email
Dr. Ashok Srivastava, Md, Ph.d., Mba, 博士. アショクスリヴァスタワ	Hematology/oncology, Car-t, I/os, Immunotherapy, Adcs, Oncolytic Virus Therapy, Targeted Therapy, Clinical Development, Medical & Safety Monitoring	New York City Metropolitan Area, United States	Email
Albert Nicholl	Board Chairman - CEO Mentor - Lifesciences & Medtech - Us Market Strategy - Fundraising - Digital Health - Bioliberty, Nami, Carcinotech, Manus		View